Nora Henrikson (she/her) is an associate investigator at Kaiser Permanente Washington Health Research Institute. She leads a research portfolio focused on interventions to improve cancer care delivery, health equity, and patient outcomes.
Her current research explores methods for improving risk notification and cascading genetic testing for family members of people with hereditary cancers as well as interventions to mitigate cancer-related financial hardship. Dr. Henrikson also leads systematic evidence reviews on cancer screening and behavioral counseling with the Kaiser Permanente Evidence-based Practice Center.
Dr. Henrikson holds affiliate faculty appointments at the University of Washington School of Public Health, Department of Health Systems and Population Health and Institute for Public Health Genetics; and the Bernard J. Tyson Kaiser Permanente School of Medicine. She has a PhD from the University of Washington School of Public Health Institute for Public Health Genetics, an MPH from the University of North Carolina at Chapel Hill, and a BA (sociology) from Lehigh University.
Social/behavioral quantitative and qualitative research; intervention design; systematic review and evidence synthesis; epidemiology; patient-provider communication
Genetic testing for cancer risk, cancer-related financial hardship
Social, ethical, and policy implications of genomics and precision health
Carlson JJ, Henrikson NB, Veenstra DL, Ramsey SD. Economic analyses of human genetics services: a systematic review. Genet Med. 2005 Oct;7(8):519-23.
The HCSRN conference is a venue for collaborative work to improve health and health care.
Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.
Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)
Leah Tuzzio, MPH, and colleagues describe an underutilized role that can help primary care become truly patient-centered.